Canagliflozin/dapagliflozin
- PDF / 169,325 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 110 Downloads / 202 Views
1 S
Fournier gangrene following off label use: 3 case reports In a retrospective pharmacovigilance study, which included all Fournier gangrene reports associated with sodium-glucose cotransporter-2 inhibitors recorded in the FDA Adverse Events Reporting System (FAERS) database between January 2004 and September 2019, 3 patients (including a 53-year-old patient and 2 patients
Data Loading...